Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company.
2004
n/a
LTM Revenue $794M
LTM EBITDA $181M
$2.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Middle East Healthcare has a last 12-month revenue of $794M and a last 12-month EBITDA of $181M.
In the most recent fiscal year, Middle East Healthcare achieved revenue of $769M and an EBITDA of $200M.
Middle East Healthcare expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Middle East Healthcare valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $708M | $769M | XXX | XXX | XXX |
Gross Profit | $181M | $271M | XXX | XXX | XXX |
Gross Margin | 26% | 35% | XXX | XXX | XXX |
EBITDA | $145M | $200M | XXX | XXX | XXX |
EBITDA Margin | 21% | 26% | XXX | XXX | XXX |
Net Profit | $20.1M | $48.1M | XXX | XXX | XXX |
Net Margin | 3% | 6% | XXX | XXX | XXX |
Net Debt | $575M | $636M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Middle East Healthcare's stock price is SAR 65 (or $17).
Middle East Healthcare has current market cap of SAR 6.0B (or $1.6B), and EV of SAR 8.4B (or $2.2B).
See Middle East Healthcare trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$2.2B | $1.6B | XXX | XXX | XXX | XXX | $0.79 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Middle East Healthcare has market cap of $1.6B and EV of $2.2B.
Middle East Healthcare's trades at 2.8x LTM EV/Revenue multiple, and 12.4x LTM EBITDA.
Analysts estimate Middle East Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Middle East Healthcare and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $2.2B | XXX | XXX | XXX |
EV/Revenue | 2.9x | XXX | XXX | XXX |
EV/EBITDA | 11.3x | XXX | XXX | XXX |
P/E | 21.3x | XXX | XXX | XXX |
P/E/Growth | 2.1x | XXX | XXX | XXX |
EV/FCF | 29.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMiddle East Healthcare's NTM/LTM revenue growth is 11%
Middle East Healthcare's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Middle East Healthcare's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Middle East Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Middle East Healthcare and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 9% | XXX | XXX | XXX | XXX |
EBITDA Margin | 26% | XXX | XXX | XXX | XXX |
EBITDA Growth | 37% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 37% | XXX | XXX | XXX | XXX |
Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 23% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Middle East Healthcare acquired XXX companies to date.
Last acquisition by Middle East Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Middle East Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Middle East Healthcare founded? | Middle East Healthcare was founded in 2004. |
Where is Middle East Healthcare headquartered? | Middle East Healthcare is headquartered in Saudi Arabia. |
Is Middle East Healthcare publicy listed? | Yes, Middle East Healthcare is a public company listed on SAU. |
What is the stock symbol of Middle East Healthcare? | Middle East Healthcare trades under 4009 ticker. |
When did Middle East Healthcare go public? | Middle East Healthcare went public in 2016. |
Who are competitors of Middle East Healthcare? | Similar companies to Middle East Healthcare include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
What is the current market cap of Middle East Healthcare? | Middle East Healthcare's current market cap is $1.6B |
What is the current revenue of Middle East Healthcare? | Middle East Healthcare's last 12-month revenue is $794M. |
What is the current EBITDA of Middle East Healthcare? | Middle East Healthcare's last 12-month EBITDA is $181M. |
What is the current EV/Revenue multiple of Middle East Healthcare? | Current revenue multiple of Middle East Healthcare is 2.8x. |
What is the current EV/EBITDA multiple of Middle East Healthcare? | Current EBITDA multiple of Middle East Healthcare is 12.4x. |
What is the current revenue growth of Middle East Healthcare? | Middle East Healthcare revenue growth between 2023 and 2024 was 9%. |
Is Middle East Healthcare profitable? | Yes, Middle East Healthcare is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.